A Proposed Lottery System to Allocate Scarce COVID-19 Medications
Open Access
- 28 July 2020
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 324 (4), 329-330
- https://doi.org/10.1001/jama.2020.11464
Abstract
This Viewpoint proposes creation of state-level central lotteries for allocating drugs like remdesivir to hospitalized patients with COVID-19, which, if pairedThis publication has 5 references indexed in Scilit:
- Faculty Opinions recommendation of Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.Published by H1 Connect ,2020
- Emergency Use Authorization of RemdesivirJAMA, 2020
- Natural Experiments in the Social SciencesPublished by Cambridge University Press (CUP) ,2012
- Use of randomisation in the Medical Research Council's clinical trial of streptomycin in pulmonary tuberculosis in the 1940sBMJ, 1998
- Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council InvestigationBMJ, 1948